|
Date
|
Update
|
|
23 December 2024
|
The resolution period has ended and NICE has received resolution requests. Therefore guidance publication will be suspended while the requests are reviewed via the resolution process. |
|
22 October 2024
|
Committee meeting: 3 |
|
30 September 2024
|
Following the draft guidance consultation, the topic will return to committee to develop the final draft guidance, this is provisionally scheduled for the 22 October 2024. |
|
28 August 2024 - 25 September 2024
|
Diagnostics consultation |
|
15 August 2024
|
We anticipate the draft guidance consultation will start week commencing 26 August 2024 and will update the webpage with the details in the near future. |
|
17 July 2024
|
Committee meeting |
|
24 May 2024
|
Declaration of interests |
|
09 May 2024
|
In progress. Updated to EVA from DG |
|
09 May 2024
|
There has been an additional delay to the draft guidance consultation for the Early Value Assessment: Artificial intelligence (AI) technologies for assessing skin lesions referred on the urgent suspected cancer pathway being circulated. Please accept our apologies, the website will be updated with any new consultation dates in due course. |
|
18 January 2024
|
Committee meeting |
|
25 October 2023
|
Scope published |
|
18 October 2023
|
Scoping workshop |
|
05 September 2023 - 03 October 2023
|
Specialist committee member recruitment |
|
05 September 2023
|
Launch |
|
24 August 2023
|
Awaiting development. Status change linked to Topic Selection Decision being set to Selected |